We are live on
!
Find out more
CCM
Cadian Capital Management Portfolio holdings
AUM
$821M
1-Year Est. Return
14.36%
This Fund
S&P 500
This Quarter
Est. Return
+11.29%
1 Year Est. Return
-14.36%
3 Year Est. Return
+4.6%
5 Year Est. Return
+8.64%
10 Year Est. Return
+282.79%
AUM
$2.05B
AUM Growth
-$37.4M
(-1.8%)
Cap. Flow
-$273M
Cap. Flow
% of AUM
-13.28%
Top 10 Holdings %
Top 10 Hldgs %
57.85%
Holding
53
New
9
Increased
15
Reduced
12
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$162M |
| 2 |
Cigna
CI
|
+$67.5M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$47.3M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$37.4M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$124M |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$113M |
| 3 |
PayPal
PYPL
|
+$93.9M |
| 4 |
GIMO
Gigamon Inc.
GIMO
|
+$76.6M |
| 5 |
SHPG
Shire pic
SHPG
|
+$48.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.83% |
| 2 | Healthcare | 20.44% |
| 3 | Communication Services | 18.6% |
| 4 | Industrials | 5.86% |
| 5 | Consumer Discretionary | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class C
GOOG
$4.36T
| $23.3M | 1.14% |
513,000
| – | – |
|
|
BPMC
27
DELISTED
Blueprint Medicines
BPMC
| $23.2M | 1.13% |
457,102
+282,202
| +161% | +$12M |
|
|
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
| $21.3M | 1.04% |
+175,000
| New | +$20.4M |
|
29
Sarepta Therapeutics
SRPT
$1.57B
| $20.9M | 1.02% |
621,458
+275,647
| +80% | +$8.98M |
|
|
APTI
30
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $20.6M | 1% |
1,185,074
+684,054
| +137% | +$10.1M |
|
31
American Tower
AMT
$80.8B
| $20M | 0.97% |
150,785
-363,600
| -71% | -$46.6M |
|
|
PTLA
32
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $18.3M | 0.89% |
326,043
-542,357
| -62% | -$21.7M |
|
33
Liberty Media Series C
FWONK
$24.6B
| $16.7M | 0.81% |
+470,601
| New | +$15.6M |
|
|
TWX
34
DELISTED
Time Warner Inc
TWX
| $15.1M | 0.73% |
+150,000
| New | +$14.9M |
|
|
EEX
35
DELISTED
Emerald Holding
EEX
| $10.9M | 0.53% |
+499,900
| New | +$10.6M |
|
36
Wayfair
W
$11.2B
| $7.67M | 0.37% |
99,800
-493,097
| -83% | -$29.2M |
|
|
CUDA
37
DELISTED
Barracuda Networks, Inc.
CUDA
| $7.5M | 0.37% |
+325,000
| New | +$7.16M |
|
|
SAGE
38
DELISTED
Sage Therapeutics
SAGE
| $4.35M | 0.21% |
54,625
-67,500
| -55% | -$4.88M |
|
39
Alibaba
BABA
$293B
| $2.82M | 0.14% |
20,000
-228,500
| -92% | -$28.2M |
|
|
ONCE
40
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.79M | 0.09% |
+30,000
| New | +$1.68M |
|
41
Box
BOX
$4.37B
| – | – |
-435,000
| Closed | -$7.09M |
|
|
DBVT
42
DBV Technologies
DBVT
$799M
| – | – |
-8,319
| Closed | -$2.93M |
|
43
Elevance Health
ELV
$81.5B
| – | – |
-110,000
| Closed | -$18.2M |
|
44
Expedia Group
EXPE
$35.4B
| – | – |
-47,039
| Closed | -$5.93M |
|
45
Pacira BioSciences
PCRX
$1.04B
| – | – |
-615,000
| Closed | -$28M |
|
46
Pegasystems
PEGA
$5.02B
| – | – |
-2,134,070
| Closed | -$46.8M |
|
|
VRNT
47
DELISTED
Verint Systems
VRNT
| – | – |
-1,224,309
| Closed | -$27.1M |
|
48
Workiva
WK
$3.36B
| – | – |
-600,082
| Closed | -$9.39M |
|
|
KTWO
49
DELISTED
K2M Group Holdings, Inc
KTWO
| – | – |
-776,449
| Closed | -$15.9M |
|
|
RPXC
50
DELISTED
RPX Corporation
RPXC
| – | – |
-247,530
| Closed | -$2.97M |
|
Similar funds
AC
DI
VT
ACM
MA
BC
SCM
FPCP
Cadian Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Cadian Capital Management held 53 positions worth $2.05B, down 1.8% from $2.09B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Cadian Capital Management withdrew a net $273M in Q2 2017, closing 13 positions and reducing 12 holdings. Its most notable exit was Gigamon Inc., an estimated $76.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Cadian Capital Management opened a new position in Altaba Inc worth $163M.
- Cadian Capital Management's largest Q2 2017 buy was Altaba Inc: 2,985,000 shares worth $163M.
- Cadian Capital Management added most to Nebius Group N.V. in Q2 2017, an estimated $37.4M increase.
- Cadian Capital Management's biggest Q2 2017 reduction was People Inc, cutting an estimated $124M.
- Cadian Capital Management fully exited Gigamon Inc. in Q2 2017, selling an estimated $76.6M.
- Cadian Capital Management's ten largest holdings make up 58% of its $2.05B portfolio in Q2 2017.
- Cadian Capital Management opened 9 new positions and closed 13 in Q2 2017.
- Cadian Capital Management's portfolio value fell 1.8% quarter-over-quarter to $2.05B.
Based on Cadian Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.